Skip to main content

Table 3 Studies on the role of CGRP in inflammatory pain

From: Calcitonin gene-related peptide and pain: a systematic review

Study

Objectives

Reported pain as part of phenotype

Method and sample size

Source of CGRP

Results

Duration of the investigated condition

Correlation between CGRP level and pain

Geber, 2007 [1]

Evaluate pain, hyperalgesia and neurosecretory function in pain models with CAP and ES

Experimental pain: CAP and ES

Samples from dermal microdialysis taken from 10 healthy volunteers. Patients rated pain levels after CAP and ES stimulation

Blood

(plasma)

CGRP increase was measured after CAP, not after ES

2 h

NR

Hamed, 2011 [2]

Determine cutaneous innervation in burn patients with chronic pain

Chronic inflammatory skin pain

Skin biopsies from 12 patients and 33 controls suffering from unilateral injury, without pain

Tissue biopsies

(skin)

Increase in CGRP density compared to controls

>24 months

CGRP-levels were higher in patients with pain compared to controls

Krämer, 2005 [3]

Explore effect of specific blockers of NEP (phosphoramidon) and ACE (captopril) on intensity of neurogenic inflammation

Experimental pain: ES

Samples from dermal microdialysis were taken from 8 healthy volunteers.

Patients quantified pain sensation during electrical stimulation using VAS

Dermal microdialysis

CGRP release could be measured after phosphoramidon perfusion

1 h

CGRP release did not correlate to pain ratings during phosphoramidon infusion

Kwak, 2014 [4]

Evaluate CGRP’s effect on wound healing process in hypertrophic scar formation

Inflammatory pain in scars

Skin biopsies from 43 patients. Biopsies were taken from scars, and also from a normal skin area

Tissue biopsies

(skin)

Increased CGRP-levels in scars compared to matched unburned skin

>12 months

Increased CGRP-levels in painful scar areas compared to normal skin

Onuoha, 2001 [5]

Examine plasma CGRP levels in patients with burns

Inflammatory pain from burn

Plasma was obtained from 13 patients immediately on hospital admission and 24 h after admission. 13 volunteers served as controls

Blood

(plasma)

CGRP levels were higher on admission, 4.9 pmol/L and after 24 h, 7.3 pmol/L, than in controls, 1.9 pmol/L

NR

NR

Salomon, 2008 [6]

Evaluate CGRP-levels in AD patients during exacerbation and disease remission

Pruritus due to AD

Plasma from 49 patients and 32 healthy controls

Blood

(plasma)

CGRP-levels were lower compared to healthy controls

Mean 20.75 years (1-55years)

High CGRP concentrations correlated with

severe pruritus

Schmelz, 1997 [7]

Examine neuropeptide release in human skin elicited by histamine iontopheresis and topical CAP application

Experimental pain: histamine iontopheresis and CAP application

Samples from dermal microdialysis taken from 10 healthy volunteers.

Patients were pain free prior start

Dermal microdialysis

CGRP concentration increased after histamine iontophoresis, but not capsaicin application

3 h

NR

Simone, 1998 [8]

Determine whether hyperalgesia after intradermal injection of CAP could be attributed to morphological changes in ENF’s

Experimental pain: intradermal CAP injection

Skin biopsies from 8 healthy volunteers

Tissue biopsies

(skin)

Complete loss of CGRP-fibers was observed 72 h after capsaicin injections. They reappeared 3–4 weeks after

6 weeks

NR

  1. ACE Angiotensin-converting enzyme, AD Atopic dermatitis, CAP Capsaicin injection, ENF’s Epidermal nerve fibers, ES Electrical current stimulation, NEP Neutral endopeptidase